Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity‐Matched Nationwide Cohort Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.041944 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Entela Bollano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden. Hauptthemen laut MEDLINE: Heart Failure, Sarcoidosis, Myocardial Ischemia, Cardiomyopathy, Dilated. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The prognosis of heart failure (HF) from ischemic heart disease (IHD) is generally worse than from dilated cardiomyopathy (DCM). The impact of prior sarcoidosis on HF outcomes is unknown. We evaluated the prognostic impact of sarcoidosis in HF compared with IHD‐HF and DCM‐HF using SwedeHF (Swedish Heart Failure Registry).
Methods
We identified patients with sarcoidosis before HF diagnosis (SC‐HF) and propensity‐matched them to patients with DCM‐HF or IHD‐HF between 2003 and 2020. The primary outcome was all‐cause mortality; secondary outcomes were cardiovascular death and hospital readmission.
Results
A total of 422 patients with SC‐HF, 6913 with DCM‐HF, and 47 164 with IHD‐HF were eligible. After 1:2 matching, 365 patients with SC‐HF (median follow‐up 2.9 years) were compared with 730 with DCM‐HF (3.6 years), and 418 with SC‐HF (2.8 years) with 836 with IHD‐HF (3.6 years). Baseline characteristics were well balanced. Patients with SC‐HF had more comorbidities than DCM‐HF but fewer than IHD‐HF. One‐year all‐cause mortality was higher in patients with SC‐HF than DCM‐HF (12.9% versus 8.6%; hazard ratio [HR, 1.51] [95% CI, 1.04–2.21]; P =0.031), along with higher readmission rates. Compared patients with IHD‐HF, those with SC‐HF also showed higher 1‐year mortality (14.8% versus 9.7%; HR, 1.58 [95% CI, 1.14–2.20]; P =0.006). Similar relative risks were observed across full follow‐up.
Conclusions
Sarcoidosis‐associated HF is linked to significantly higher mortality than both DCM and IHD and to higher morbidity than DCM. These findings underscore the need for heightened clinical attention and may warrant tailored management strategies for this high‐risk group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy University of Gothenburg Sweden.
- Department of Medicine, Geriatrics and Emergency Medicine Sahlgrenska University Hospital/Östra, Region Västra Götaland Gothenburg Sweden.
- APNC Sweden Mölndal Sweden.
- Departments of Clinical Physiology and Radiology Sahlgrenska University Hospital Gothenburg Sweden.
- Department of Cardiology Linköping University Linköping Sweden.
ORCID-Profile: Entela Bollano, Michael Fu, Aldina Pivodic, Christian L Polte, Ulf Dahlström, Emanuele Bobbio
Zitieren
APA
Bollano, E., Fu, M., Pivodic, A., Polte, C. L., Dahlström, U., & Bobbio, E. (2025). Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity‐Matched Nationwide Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041944
Vancouver
Bollano E, Fu M, Pivodic A, Polte CL, Dahlström U, Bobbio E. Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity‐Matched Nationwide Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041944
BibTeX
@article{Bollano2025,
author = {Bollano, Entela and Fu, Michael and Pivodic, Aldina and Polte, Christian L and Dahlström, Ulf and Bobbio, Emanuele},
title = {Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity‐Matched Nationwide Cohort Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041944}
}
EUVIMED